Fox, Donald Munro, M.D., P.C. Report issue

Academic/Hospital

Organization Overview

First Clinical Trial
2014
NCT02244671
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2014

Timeline

NOW
  • Now

Active Ingredients

Drugs in Other Trials (2)

platelet-rich plasma (1 trial)

rimabotulinumtoxinB (Myobloc) (1 trial)

Indications

Overview

  • Highest Phase: Phase 0
  • # of Trials: 1
  • # of Trial APIs: 2